Decrease in New Cancer Diagnoses Seen in 2020
There was a decrease in new cancer diagnoses, relative to expected numbers, between March 2020 and May 2020, according to a report.
Diagnosis & Disease Information
Language Barriers Hinder Access to Cancer Care Even Before Patients See a Doctor
Language barriers may hinder access to cancer care before patients even encounter a physician, a new study suggests.
Incidence of Early-Onset Cancers Increasing in the US
The incidence of early-onset cancers (diagnosed before age 50) has been increasing in recent years, according to a population-based study.
Prevalence of TERT Mutations in Cancer Patients Differs by Race and Sex
The prevalence of TERT promoter mutations among patients with cancer differs by race and sex, a large study suggests.
Gavreto Indication for RET-Mutant Medullary Thyroid Cancer Withdrawn
Patients receiving Gavreto for RET-mutant MTC should be informed of the withdrawal and given other care options.
Adding Lenalidomide to Cediranib Confers No Benefit in RAI-Refractory Thyroid Cancer
Lenalidomide does not improve upon treatment with cediranib in patients with radioactive iodine-refractory differentiated thyroid cancer, a study suggests.
ACS Report Shows Prostate Cancer on the Rise, Cervical Cancer on the Decline
A report from the American Cancer Society reveals trends in cancer incidence and mortality over time and includes projections for 2023.
Many Thyroid Cancer Survivors Cite Inadequate Pretreatment Understanding
Many thyroid cancer survivors said they lacked understanding of their treatment before receiving it.
Lifestyle May Counter Genetic Risk for Thyroid Cancer
The highest risk of thyroid cancer was seen in patients with both high genetic risk and an unfavorable lifestyle.
Cabozantinib Improves PFS in Radioiodine-Refractory Differentiated Thyroid Cancer
Cabozantinib prolongs progression-free survival in patients with previously treated radioiodine-refractory differentiated thyroid cancer, a phase 3 trial suggests.
- Loading...
Loading...
Next post in Endocrine Cancer
Loading... 
Loading...